Atrium Therapeutics, Inc. (RNA) Form 10-Q Quarterly Reports
Atrium Therapeutics, Inc. (RNA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RNA
CIK: 2093101
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerElijah Rinn
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K/A | 2026-10-09 | 2026-10-07 | 8-K/A | 0001193125-26-418417 | View SEC Doc Filr Page |
| 8-K | 2026-10-08 | 2026-10-07 | 8-K | 0001193125-26-417402 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 | 0001193125-26-397971 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 | 0001193125-26-397967 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 | 0001193125-26-397955 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 | 0001193125-26-397951 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 | 0001193125-26-397948 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 | 0001193125-26-397944 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 | 0001193125-26-397941 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 | 0001193125-26-397936 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000917 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000902664-26-003500 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000080255-26-000590 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349488 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349482 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002192 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-14 | 8-K | 0001193125-26-303393 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001346824-26-000145 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001193125-26-224243 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001193125-26-224238 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-27 | — | SCHEDULE 13G Filing | 0002012383-26-001673 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | 4 | 0001193125-26-170964 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | 4 | 0001193125-26-170963 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | 4 | 0001193125-26-170960 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | 4 | 0001193125-26-170914 | View SEC Doc Filr Page |